Merantix Capital has closed a €103m fund to invest in early-stage, AI-native teams across Europe, the Berlin firm announced on 4 June. The fund is more than three times the size of its first vehicle, which co-founders Rasmus Rothe and Adrian Locher rai…
The discipline was the whole identity. For more than twenty years Benchmark kept its funds around $425m and backed only young companies, taking a roughly 20% stake in each and trusting that selectivity, not scale, would produce the returns. That model …
The public markets have been asked whether they believe in AI, and they have answered with $85 billion. Alphabet’s record-shattering equity offering, which priced on 2 June, is not just the largest stock sale in tech history. It is the largest equity o…
Anthropic has selected Morgan Stanley and Goldman Sachs to lead its initial public offering, with JPMorgan Chase also working on the deal, Bloomberg reported on Tuesday. The Claude developer is weighing going public as soon as October after filing conf…
Eighteen months ago Suno was the AI company the music industry wanted to destroy. Every major record label had sued it, accusing it of training its models on copyrighted songs without permission. Now the labels are its partners, and investors have repr…
General Catalyst has decided it wants exposure to Factorial in two ways at once. The Barcelona software company has closed a $150M Series D led by the firm at a $2.5bn valuation, and General Catalyst is committing a further $540M through a separate veh…
Science can already tell you what a molecule is and what it looks like. What it has never been able to tell you, cheaply and at scale, is how the thing behaves once it meets the messy conditions of the real world. That gap is where drugs quietly fail i…
The appetite was the story. Applied Aerospace & Defense priced its initial public offering on Tuesday at $20 a share, raising $650M, and by the time the book closed the deal was said to be about ten times oversubscribed. A company that makes fusela…
DeepSeek has spent eighteen months as the most talked-about AI lab that almost nobody could invest in. That is about to change. The Chinese startup is slated to raise roughly 50 billion yuan, about $7bn, in its first external funding round, according t…
The Cambridge clinic has regulatory approval to triage, treat and discharge patients without a human in the loop. Now it wants to do the same for hip, knee and pelvic-health conditions. The unusual thing about Flok Health is not that an AI runs a physi…